Literature DB >> 10701566

Taenia crassiceps cysticercosis: protective effect and immune response elicited by DNA immunization.

C Cruz-Revilla1, G Rosas, G Fragoso, F López-Casillas, A Toledo, C Larralde, E Sciutto.   

Abstract

The nucleotide sequence of a protective recombinant antigen of Taenia crassiceps cysticerci present in all stages of Taenia solium (KETc7), cloned into pcDNA3 plasmid with the signal peptide sequence of the beta-glycan receptor (pTc-sp7), has been shown to be effective in protecting mice against experimental infection of T. crassiceps. To explore further the possibilities of this form of immunization and the immune response induced, mice were injected intramuscularly (i.m.) or intradermally (i.d.) with 3 doses of pTc-sp7. Similar levels of resistance were found using either i.m. or i.d. immunization. Spleen cells from i.d. and i.m. DNA immunized mice induced a specific T-cell response to T. crassiceps antigens and to a synthetic peptide from the immunogen itself (GK-1). Proliferated cells were especially enriched in CD8+ CD4- T-lymphocytes. A clear increase in the percentage of CD3+ cells that produce gamma-interferon and interleukin-2 was detected when measuring the intracellular cytokine production, an indication of the pTc-sp7 capacity to induce an effective cellular response. These results provide encouraging information on the use of KETc7 in the prevention of cysticercosis as well as a first insight into the characterization of the immune response induced by pTc-sp7 that hints to the relevance of cellular immunity in protection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10701566     DOI: 10.1645/0022-3395(2000)086[0067:TCCPEA]2.0.CO;2

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  6 in total

1.  Experimental and Theoretical Approaches To Investigate the Immunogenicity of Taenia solium-Derived KE7 Antigen.

Authors:  Raúl J Bobes; José Navarrete-Perea; Adrián Ochoa-Leyva; Víctor Hugo Anaya; Marisela Hernández; Jacquelynne Cervantes-Torres; Karel Estrada; Filiberto Sánchez-Lopez; Xavier Soberón; Gabriela Rosas; Cáris Maroni Nunes; Martín García-Varela; Rogerio Rafael Sotelo-Mundo; Alonso Alexis López-Zavala; Goar Gevorkian; Gonzalo Acero; Juan P Laclette; Gladis Fragoso; Edda Sciutto
Journal:  Infect Immun       Date:  2017-11-17       Impact factor: 3.441

2.  Two epitopes shared by Taenia crassiceps and Taenia solium confer protection against murine T. crassiceps cysticercosis along with a prominent T1 response.

Authors:  A Toledo; G Fragoso; G Rosas; M Hernández; G Gevorkian; F López-Casillas; B Hernández; G Acero; M Huerta; C Larralde; E Sciutto
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

Review 3.  Human cysticercosis and Indian scenario: a review.

Authors:  Kashi Nath Prasad; Amit Prasad; Avantika Verma; Aloukick Kumar Singh
Journal:  J Biosci       Date:  2008-11       Impact factor: 1.826

4.  The initial immune response during experimental cysticercosis is of the mixed Th1/Th2 type.

Authors:  S A Toenjes; R E Kuhn
Journal:  Parasitol Res       Date:  2002-12-17       Impact factor: 2.289

Review 5.  Fact or hypothesis: Taenia crassiceps as a model for Taenia solium, and the S3Pvac vaccine.

Authors:  M W Lightowlers
Journal:  Parasite Immunol       Date:  2010 Nov-Dec       Impact factor: 2.280

6.  Lipopolysaccharide-initiated persistent rhinitis causes gliosis and synaptic loss in the olfactory bulb.

Authors:  Sanae Hasegawa-Ishii; Atsuyoshi Shimada; Fumiaki Imamura
Journal:  Sci Rep       Date:  2017-09-14       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.